Cargando…

Olfactory Reference Syndrome Treated With Lurasidone and Cognitive Behavioral Therapy: A Case Report

Olfactory Reference syndrome (ORS) is characterized by patients falsely believing that they exude a foul body odor, which is embarrassing and disturbing to the patient. The increased anxiety due to this belief leads to compulsive behaviors, social anxiety, and functional impairment. ORS poses enormo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Das, Soumitra, Sekharan, Lokesh, Prasad, Sakshi, Abdul Rasool, Aniqa, Walia, Namrata, Bachu, Anil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716598/ https://www.ncbi.nlm.nih.gov/pubmed/36466723 http://dx.doi.org/10.1177/11795476221139396

Ejemplares similares

Lurasidone-induced Oculogyric Crisis
por: Das, Soumitra, et al.
Publicado: (2017)

Severe Extrapyramidal Syndrome Caused by Lurasidone Low Dose
por: Das, Soumitra, et al.
Publicado: (2018)

Recurrent Catatonia due to Episodic Obsessive-Compulsive Disorder
por: Das, Soumitra, et al.
Publicado: (2022)

A case of Kleine-Levin syndrome successfully treated with Escitalopram
por: Reddy, Balaswamy, et al.
Publicado: (2022)

F60. INFLAMMATORY MARKERS AND COGNITIVE PERFORMANCE IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH LURASIDONE
por: Pikalov, Andrei, et al.
Publicado: (2018)

Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia
por: Meltzer, Herbert Y., et al.
Publicado: (2020)

Lurasidone hydrochloride
por: Zhang, Hua, et al.
Publicado: (2012)

Antipsychotic treatments; focus on lurasidone
por: Sumiyoshi, Tomiki
Publicado: (2013)

Lurasidone-induced Parkinsonism and Hyperprolactinemia
por: Suthar, Navratan, et al.
Publicado: (2019)

Lurasidone in treatment of manic episode
por: Sánchez-Rivero, I.
Publicado: (2022)

Treatment persistence in patients with schizophrenia treated with lurasidone in Italian clinical practice
por: Fagiolini, Andrea, et al.
Publicado: (2022)

Lurasidone for Treating Schizophrenia and Bipolar Depression: A Review of Its Efficacy
por: Tarzian, Martin, et al.
Publicado: (2023)

Delirium in a Relatively Young Person due to COVID-19 Infection
por: Das, Soumitra, et al.
Publicado: (2023)

Clinical potential of lurasidone in the management of schizophrenia
por: Samalin, Ludovic, et al.
Publicado: (2011)

Critical appraisal of lurasidone in the management of schizophrenia
por: Caccia, Silvio, et al.
Publicado: (2012)

Length of hospital stays in patients with psychosis before and after starting on lurasidone
por: Nguyen, Uyen, et al.
Publicado: (2021)

Lurasidone as a potential therapy for bipolar disorder
por: Woo, Young Sup, et al.
Publicado: (2013)

Lurasidone for the Treatment of Irritability Associated with Autistic Disorder
por: Loebel, Antony, et al.
Publicado: (2015)

The clinical utility of lurasidone in schizophrenia: patient considerations
por: Harvey, Philip D
Publicado: (2015)

Identification of clinical phenotypes in schizophrenia: the role of lurasidone
por: Riva, Marco Andrea, et al.
Publicado: (2021)

Lurasidone for the treatment of schizophrenia in adult and paediatric populations
por: Guilera, Teresa, et al.
Publicado: (2023)

Lurasidone-induced mania: A case report
por: Fernández, T., et al.
Publicado: (2022)

Olfactory Reference Syndrome with Suicidal Attempt Treated with Pimozide and Fluvoxamine
por: Jegede, Oluwole, et al.
Publicado: (2018)

Lurasidone for the treatment of bipolar depression: an evidence-based review
por: Franklin, Rachel, et al.
Publicado: (2015)

Management of bipolar I depression: clinical utility of lurasidone
por: Findlay, Lillian Jan, et al.
Publicado: (2015)

Schizophrenia relapse, patient considerations, and potential role of lurasidone
por: Citrome, Leslie
Publicado: (2016)

Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia
por: Javed, Afzal, et al.
Publicado: (2019)

Lurasidone-induced anemia: Is there a need for hematological monitoring?
por: Kirpekar, Vivek C., et al.
Publicado: (2019)

Risperidone-induced retrograde ejaculation and lurasidone may be the alternative
por: Shanmugasundaram, Natarajan, et al.
Publicado: (2019)

TULIP study: Trail of Lurasidone in bipolar disorder in Pakistan()
por: Khan, Nasar, et al.
Publicado: (2021)

Lurasidone Augmentation of Clozapine in Schizophrenia—Retrospective Chart Review
por: Siwek, Marcin, et al.
Publicado: (2023)

Lurasidone for the Treatment of Schizophrenia: Design, Development, and Place in Therapy
por: Miura, Itaru, et al.
Publicado: (2023)

Lurasidone versus Quetiapine for Cognitive Impairments in Young Patients with Bipolar Depression: A Randomized, Controlled Study
por: Diao, Xiangyuan, et al.
Publicado: (2022)

Corticosteroid-Induced Psychosis: A Report of Three Cases
por: Bachu, Anil K, et al.
Publicado: (2023)

Is olfactory reference syndrome an OCD?
por: Singh, Gurvinder Pal
Publicado: (2006)

Update on the development of lurasidone as a treatment for patients with acute schizophrenia
por: Yasui-Furukori, Norio
Publicado: (2012)

Solubility enhancement studies on lurasidone hydrochloride using mixed hydrotropy
por: Madan, Jyotsana R., et al.
Publicado: (2015)

Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia
por: Rajagopalan, Krithika, et al.
Publicado: (2016)

Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone
por: Sood, Shabnam
Publicado: (2017)

Lurasidone Induced Thrombocytopenia: Is it a Signal of Drug Induced Myelosuppression?
por: Rafi, Mohammad, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0uq6oa5gbsdqi9q133ikcc571d